My research is focused on decision analysis of common clinical scenarios in genitourinary cancers, in particular the screening and treatment of prostate cancer. I am currently constructing a decision analytic model of screening strategies for prostate cancer based on primary data obtained from the European Randomised Study of Screening for Prostate Cancer, and collaborators in Orebro, Sweden. I also focus on treatment options for clinically localized, low-risk prostate cancer. I have recently completed a cost-effectiveness analysis of treatment strategies for low risk prostate cancer that is being used by the Employers Action Coalition on Healthcare (EACH), a group consisting of employers, payers, and providers committed to using the results generated by this model for policy decisions. This work has been presented at ASCO’s Genitourinary Cancers Symposium and in a moderated poster session at ASCO’s Annual Meeting. A completed effectiveness analysis of treatment options for low-risk prostate cancer has just been published.